NewsBenzingaUPDATE: GSK Q3 Adj. EPS $1.47 Beats $1.40 Estimate, Sales $11.948B Beat $11.800B Estimate UPDATE: GSK Q3 Adj. EPS $1.47 Beats $1.40 Estimate, Sales $11.948B Beat $11.800B Estimate Benzinga 2026.10.28 14:23 (GMT+0) Open on Benzinga Other news GE HealthCare Lifts Forecasts on Healthy Hospital Spending Truist Securities Maintains Buy on Zymeworks, Raises Price Target to $35 TD Cowen Maintains Hold on United Parcel Service, Raises Price Target to $116 Truist Securities Maintains Buy on United Parcel Service, Raises Price Target to $120 Truist Securities Maintains Buy on Sensata Technologies, Lowers Price Target to $57 Essex Property Trust Q3 2026 Earnings Call Transcript
